Agronomics announces sale of InSilico Medicine Inc shares

Drug testing lab

Agronomics plc (LON:ANIC), the leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat, has announced the disposal of its total holding of 23,147 shares in Insilico Medicine Inc for US $669,775 (£475,540), representing an IRR of 54%. Insilico Medicine was a legacy portfolio holding, acquired for £92,755 between June 2017 and July 2018. The proceeds will provide Agronomics with further funding for new and existing opportunities within the field of cellular agriculture.

The remaining legacy positions in the Agronomics portfolio continue to be monitored and will be sold down as opportunities arise.

You might also enjoy reading  Surface Transforms analyst Zeus upgrades forecasts

Good news travels fast (but only if you make that happen). Share on:

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on reddit

AIM All Share Index